Last reviewed · How we verify

Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with sickle cell disease

1 treatments

Approved treatments

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

Frequently asked questions about Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with sickle cell disease

What drugs treat Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with sickle cell disease?

Tracked treatments include Ppsv23.

What is the treatment for Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with sickle cell disease?

Standard treatment for Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with sickle cell disease includes Ppsv23. See the treatment landscape page for first-line, second-line and salvage options.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing